In a regulatory filing, Progyny (PGNY) disclosed that executive chairman David Schlanger bought 150K shares of Progyny common stock on December 26 at $14.68 per share. Following the release of the filing, in pre-market trading, shares of Progyny are higher by 5.4% to $15.50.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY: